Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Fröhlich, E.
The Effects of Obesity on Lung Physiology, the Prevalence and Severity of Chronic Pulmonary Diseases, and Inhalation Treatment
DRUG DES DEV THER. 2025; 19: 11885-11900. Doi: 10.2147/DDDT.S564912
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Fröhlich Eleonore
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Obesity itself induces macroscopic, microscopic, and functional changes in the lungs, potentially making obese individuals more susceptible to acute and chronic pulmonary diseases. Apart from direct contribution to the course of the disease, obesity-induced alterations of the respiratory tract may influence the delivery and efficacy of inhaled formulations. The review examined obesityinduced changes in healthy lungs and the link between obesity and the prevalence and severity of chronic respiratory diseases. Fat accumulation at the tissue and cellular levels, as well as an increased thickness of the smooth muscle layer and an increase in the extracellular matrix, caused a reduction in lung compliance, resistance, reactance, and lung volumes. Conversely, airway hyperreactivity and closure increased, and ventilation/perfusion mismatch was observed. Changes in deposition, metabolization, and permeation across the respiratory barrier in obese lungs may alter the availability of inhaled drugs. Obesity-induced lung alterations may in part explain the higher reported doses of the bronchodilators and anticholinergics in obese compared to normal-weight asthma patients. Based on the observed changes, formulations with smaller particle sizes that require lower airflow may be more effective for obese patients with obstructive lung diseases.

Find related publications in this database (Keywords)
lung morphology
lung function
drug bioavailability
asthma
COPD
cystic fibrosis
© Med Uni Graz • Impressum